In 2005, Arul Chinnaiyan, M.D., Ph.D., and his lab found when a gene regulated by androgens called TMPRSS2 fuses with a transcription factor called ERG, it triggers the development of prostate cancer. This gene fusion was the first ever identified in solid tumors. In the nearly two decades since, the Chinnaiyan lab has refined its discovery, understanding how the hormone androgen regulates this gene fusion and developing a urine-based screening test to better detect prostate cancer.
Meet Madison McTevia, M.A., C.C.L.S., clinical specialist and program coordinator for the Families Facing Cancer program at the Rogel Cancer Center. And, meet Kevin (or "Kev" as he affectionally known) her 210-pound potbelly pig.
Paul Swiecicki, M.D., has been named medical director for the Clinical Research Specimen Processing (CRSP) laboratory at the U-M Rogel Cancer Center. Swiecicki, along with lab manager Keri Innes, will oversee the lab's expansion into an additional space on the Rogel building's 7th floor to accommodate an increasing workload.
The laboratory is responsible for managing bio-specimens for all clinical oncology trials in progress at Rogel Cancer Center.
MENU
